Literature DB >> 14711129

Evidence-based treatment for schizophrenia.

Anthony F Lehman1, Robert W Buchanan, Faith B Dickerson, Lisa B Dixon, Richard Goldberg, Lisa Green-Paden, Julie Kreyenbuhl.   

Abstract

Taken together, the research on what treatments help people with schizophrenia point to the value of treatment programs that combine medications with a range of psychosocial services. Provision of such packages of services likely reduces the need for crisis-oriented care hospitalizations and emergency room visits and enables greater recovery. For most people with schizophrenia, the combination of psychopharmacological and psychosocial interventions improves outcomes. Several psychosocial treatments have demonstrated efficacy. These include family intervention, supported employment, assertive community treatment, skills training, and CBT. In the same way that psychopharmacologic management must be tailored individually to the needs and preferences of the patient, so too should the selection of psychosocial treatments. At the very least, all people with schizophrenia should be provided with education about their illness. Beyond illness education, all of the recommended psychosocial interventions would be used rarely during any one phase of illness for an individual. Some psychosocial treatments share treatment components, and patients have different clinical and social needs at different points in their illness course. Knowledge regarding how best to combine treatments to optimize outcomes is scarce.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711129     DOI: 10.1016/s0193-953x(03)00070-4

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  7 in total

1.  Efficacy of bifocal diagnosis-independent group psychoeducation in severe psychiatric disorders: results from a randomized controlled trial.

Authors:  K Rabovsky; M Trombini; D Allemann; G Stoppe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08       Impact factor: 5.270

2.  Developing a framework to support shared decision making for youth mental health medication treatment.

Authors:  Elizabeth L Crickard; Megan S O'Brien; Charles A Rapp; Cheryl L Holmes
Journal:  Community Ment Health J       Date:  2010-06-23

Review 3.  Recovery in schizophrenia: reality or mere slogan.

Authors:  Natalie B Slopen; Patrick W Corrigan
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

Review 4.  Psychotherapy for schizophrenia in the year 2030: prognosis and prognostication.

Authors:  William Spaulding; Jeffrey Nolting
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

Review 5.  [The role of psychoeducation in the treatment of psychiatric inpatients].

Authors:  K Rabovsky; G Stoppe
Journal:  Nervenarzt       Date:  2006-05       Impact factor: 1.214

6.  Atypical presentations of atypical antipsychotics.

Authors:  Cpt Christopher K Lind; Cpt Lisa R Carchedi; Ltc James J Staudenmeier; Ltc P Carroll J Diebold
Journal:  Psychiatry (Edgmont)       Date:  2005-06

7.  A randomized controlled trial of a mindfulness-based intervention program for people with schizophrenia: 6-month follow-up.

Authors:  Li-Qun Wang; Wai Tong Chien; Lai King Yip; Thanos Karatzias
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-07       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.